Eric Zhang
Vorstandsvorsitzender bei AKSO Biopharmaceutical, Inc.
Vermögen: 174 010 $ am 31.12.2023
Profil
Eric Zhang is the founder of AKSO Biopharmaceutical, Inc. Prior to founding AKSO Biopharmaceutical, he worked as a Director at Versartis, Inc. He also worked as a Director at Aravive Biologics, Inc. from 2016 to 2018.
From 2018 to 2023, he served as an Independent Director at Aravive, Inc. Mr. Zhang received his undergraduate degree from Queen's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARAVIVE, INC.
1,91% | 03.08.2023 | 1 403 303 ( 1,91% ) | 174 010 $ | 31.12.2023 |
Aktive Positionen von Eric Zhang
| Unternehmen | Position | Beginn |
|---|---|---|
| AKSO Biopharmaceutical, Inc. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Eric Zhang
| Unternehmen | Position | Ende |
|---|---|---|
| ARAVIVE, INC. | Direktor/Vorstandsmitglied | 02.10.2023 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 01.10.2018 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Eric Zhang
| Queen's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
| AKSO Biopharmaceutical, Inc. |
